None · None

Embecta Corporation EMBC

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes.

Company profile

Business mix

  • The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes.
  • It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Current key questions

  • Can the company's products, services, or pipeline expand adoption within medical instruments & supplies?
  • How do reimbursement, regulation, clinical data, patents, and commercial execution affect growth?
  • Can margins and cash flow improve while funding research, manufacturing, or go-to-market investment?
Holders 1 Current sample portfolio
Public mentions 0 Videos / interviews / letters

Current firm holders

Firm Weight Value Filing period
Yacktman Asset Management Stephen Yacktman 0.4% $32.5M 2026-03-31

Recent trading changes over the last 4 quarters

Net buyers 1 Last 4 13F filing periods
Net reducers 0 Last 4 13F filing periods
Unchanged holders 0 Share count unchanged
Increase amount $11.6M Estimated from net added shares
Reduction amount $0 Estimated from net reduced shares
Net share change / base shares +55.8% +1,314,560 / 2,357,317
Yacktman Asset Management Stephen Yacktman 4 filing periods
13F 2025-06-30 Filed 2025-08-06
Minor increase Shares 0.7% 13F value change -$7.1M
13F 2025-09-30 Filed 2025-11-04
Minor reduction Shares -7.7% 13F value change +$7.9M
13F 2025-12-31 Filed 2026-02-03
Minor increase Shares 3.2% 13F value change -$4.0M
13F 2026-03-31 Filed 2026-05-01
Major increase Shares 62.3% 13F value change +$5.6M
Settlement As of 13F 2026-03-31 · Filed 2026-05-01
Base shares 2,357,317 Last 4 periods +1,314,560 (+55.8%) Total shares 3,671,877 Value $32.5M

Recent mentions

No public mentions.